Thus, among the group formerly categorized as hormonal receptor positive breast cancer (majority ER+ breast cancer), we found increased risk for both luminal A (ER+, PR+, HER2−) and luminal B (ER+, PR+, HER2+) breast cancers. Here, PGR is linked to breast cancer.